0000927066-23-000117.txt : 20230512
0000927066-23-000117.hdr.sgml : 20230512
20230512212002
ACCESSION NUMBER: 0000927066-23-000117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230510
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodriguez Javier
CENTRAL INDEX KEY: 0001415548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 23917988
MAIL ADDRESS:
STREET 1: 601 HAWAII ST.
CITY: EL SEGUNDO
STATE: CA
ZIP: 90245
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1683940791.xml
FORM 4
X0407
4
2023-05-10
0
0000927066
DAVITA INC.
DVA
0001415548
Rodriguez Javier
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-05-10
4
M
0
88213
66.29
A
403835
D
Common Stock
2023-05-10
4
D
0
58059
100.72
D
345776
D
Common Stock
2023-05-10
4
F
0
13238
100.72
D
332538
D
Common Stock
2023-05-10
4
S
0
15516
99.383
D
317022
D
Common Stock
2023-05-10
4
S
0
1400
100.0443
D
315622
D
Common Stock
2023-05-10
4
A
0
58780
0
A
374402
D
Stock Appreciation Rights
66.29
2023-05-10
4
M
0
88213
0
D
2021-05-15
2023-05-15
Common Stock
88213
0
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the weighted average sale price of $99.383. The range of prices for the sale of these shares was $98.96 - $99.94 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of $100.0443. The range of prices for the sale of these shares was $99.99 - $100.12 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019, of which 100% will vest on May 15, 2023.
The Stock Appreciation Rights were granted on May 15, 2018, which vested 50% each on May 15, 2021 and May 15, 2022.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2023-05-12